Ray tracing-based power calculation leads to better refractive outcomes

More individual IOL power calculation is possible, for example in eyes with irregular cornea or those eyes who have previously undergone refractive surgery.

Ray tracing-based power calculation leads to better refractive outcomes
Leigh Spielberg
Leigh Spielberg
Published: Friday, October 13, 2017
Nino Hirnschall MD Nino Hirnschall, Vienna Institute for Research in Ocular Surgery, Austria, said there are two potential advantages of a ray tracing-based IOL power calculation. “First, more individual IOL power calculation is possible, for example in eyes with irregular cornea or those eyes who have previously undergone refractive surgery. Second, because it is a purely physical approach, no empirical ‘optimisation’ is required,” said Dr Hirnschall. In the ray tracing-based method, IOL selection is based on predicted visual acuity and a neuronal weighted retinal image quality metric (RIQM). It involves ssOCT-based biometry and keratometry, incorporating anterior and posterior corneal surfaces, corneal thickness, axial length, anterior chamber depth and white-to-white distance. Dr Hirnschall’s team conducted a prospective study of 40 eyes comparing outcomes obtained using the ray tracing method with those obtained with a triple-optimised Haigis formula. “Ray tracing offers more detailed information of the cornea, as well as anatomical data instead of estimated lens position, both of which lead to a better refractive outcome,” said Dr Hirnschall. A potential limitation of the method is that exact IOL design information is needed. Ray tracing resulted in a 2.5% increase in outcomes within 0.5D and 0.75D of target refraction, and a 10% increase in those coming within 1.00D.  
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...